XNAS · SDGR
-11.30% · -$2.88 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Schrodinger, Inc. Common Stock

Schrodinger, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$22.60
Card
Relationship Map

Follow $SDGR

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $SDGR by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
SDGR
Schrodinger, Inc. Common Stock
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

85/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
Sovereign

Why is SDGR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Schrodinger, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
850
Country
US

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$25.69
Day high
$26.00
Day low
$22.57
Previous close
$25.48
52W high
$32.60
-30.67% from high
52W low
$11.07
54% of range
Market cap
$1.7B
Beta
1.43
Shares out
74.8M
Avg volume
2.8M
VWAP
$25.48
Last session
Price history computed in-house
1W
-17.16%
1M
-22.12%
3M
+50.67%
1Y
+17.04%
YTD
+26.40%
SMA 50 $23.53 · below
SMA 200 $16.40 · above
52W position 54%

SDGR overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Public disclosures

Congress activity in SDGR

No receipt-qualified filings found.

Federal contracts

SDGR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SDGR in this window.
Lobbying spend

SDGR lobbying filings, year to date.

Registered lobbying filings matched to Schrodinger, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SDGR in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for SDGR.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.